Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections

Clinical Immunology

Volumn 127, Issue 2, 2008, Pages 214-224

  Im, Jin S ^a   Kang, Tae Jin ^b   Lee, Seong Beom ^b   Kim, Chi Hong ^b   Lee, Sang Haak ^b   Venkataswamy, Manjunatha M ^a   Serfass, Evan R ^a   Chen, Bing ^a   Illarionov, Petr A ^c   Besra, Gurdyal S ^c   Jacobs Jr , William R ^a   Chae, Gue Tae ^b   Porcelli, Steven A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b The Catholic University of Korea   (South Korea)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Galactosylceramide; CD1d; Glycolipid; Invariant natural killer T cells; Leprosy; Mycobacteria; Tuberculosis

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; TETRAMER;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CD4 CD8 RATIO; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HUMAN; LEPROSY; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD1; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEPROSY; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 41549168084     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.12.005     Document Type: Article

References (52)

1. Hussain T. Leprosy and tuberculosis: an insight-review. Crit. Rev. Microbiol. 33 (2007) 15-66
2. Chan J., and Flynn J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110 (2004) 2-12
3. Gomez-Reino J.J., Carmona L., and Angel D.M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum. 57 (2007) 756-761
4. Sita-Lumsden A., Lapthorn G., Swaminathan R., and Milburn H.J. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 62 (2007) 1003-1007
5. Lin P.L., Plessner H.L., Voitenok N.N., and Flynn J.L. Tumor necrosis factor and tuberculosis. J. Investig. Dermatol. Symp. Proc. 12 (2007) 22-25
6. Alban A., and Andersen N.B. HIV/AIDS' spread and impact on other health-related millennium development goals-secondary publication. Dan. Med. Bull. 4 (2007) 163-166
7. Chen X., Zhou B., Li M., et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123 (2007) 50-59
8. Mendelson M., Hanekom W.A., Ntutela S., et al. Quantitative and functional differences between peripheral blood myeloid dendritic cells from patients with pleural and parenchymal lung tuberculosis. Clin. Vaccine Immunol. 13 (2006) 1299-1306
9. Swann J.B., Coquet J.M., Smyth M.J., and Godfrey D.I. CD1-restricted T cells and tumor immunity. Curr. Top. Microbiol. Immunol. 314 (2007) 293-323
10. Lee P.T., Benlagha K., Teyton L., and Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195 (2002) 637-641
11. Gumperz J.E., Miyake S., Yamamura T., and Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195 (2002) 625-636
12. Yu K.O., and Porcelli S.A. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol. Lett. 100 (2005) 42-55
13. Meyer E.H., DeKruyff R.H., and Umetsu D.T. iNKT cells in allergic disease. Curr. Top. Microbiol. Immunol. 314 (2007) 269-291
14. van Dieren J.M., van der Woude C.J., Kuipers E.J., et al. Roles of CD1d-restricted NKT cells in the intestine. Inflamm. Bowel.Dis. 13 (2007) 1146-1152
15. Behar S.M., and Porcelli S.A. CD1-restricted T cells in host defense to infectious diseases. Curr. Top. Microbiol. Immunol. 314 (2007) 215-250
16. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., and Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189 (1999) 1973-1980
17. Sugawara I., Yamada H., Mizuno S., et al. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb.) 82 (2002) 97-104
18. Sousa A.O., Mazzaccaro R.J., Russell R.G., et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4204-4208
19. D'Souza C.D., Cooper A.M., Frank A.A., et al. A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am. J. Respir. Cell Mol. Biol. 23 (2000) 188-193
20. Kawakami K., Kinjo Y., Uezu K., et al. Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol. 46 (2002) 207-210
21. Skold M., Xiong X., Illarionov P.A., Besra G.S., and Behar S.M. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J. Immunol. 175 (2005) 3584-3593
22. Chackerian A., Alt J., Perera V., and Behar S.M. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70 (2002) 6302-6309
23. Gansert J.L., Kiessler V., Engele M., et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol. 170 (2003) 3154-3161
24. Im J.S., Tapinos N., Chae G.T., et al. Expression of CD1d molecules by human Schwann cells and potential interactions with immunoregulatory invariant NK T cells. J. Immunol. 177 (2006) 5226-5235
25. Smith C.L., Peter A.T., and Appell K.M. Effects of stepwise cryodilution prior to freezing and stepwise post-thaw rehydration on viability of ovine embryos. Theriogenology 41 (1994) 1267-1271
26. Im J.S., Yu K.O., Illarionov P.A., et al. Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. J. Biol. Chem. 279 (2004) 299-310
27. Yu K.O., Im J.S., Molano A., et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3383-3388
28. Yu K.O., Im J.S., Molano A., et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3383-3388
29. Sambandamurthy V.K., Derrick S.C., Hsu T., et al. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24 (2006) 6309-6320
30. Lee P.T., Putnam A., Benlagha K., et al. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110 (2002) 793-800
31. Kukreja A., Cost G., Marker J., et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109 (2002) 131-140
32. Hamzaoui K., Kamoun M., Houman H., et al. Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behcet's disease. J. Neuroimmunol. 175 (2006) 160-168
33. Crough T., Purdie D.M., Okai M., et al. Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies. Br. J. Cancer 91 (2004) 1880-1886
34. Inoue M., Kanto T., Miyatake H., et al. Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection. J. Hepatol. 45 (2006) 190-196
35. Grose R.H., Cummins A.G., and Thompson F.M. Deficiency of invariant natural killer T cells in coeliac disease. Gut 56 (2007) 790-795
36. Grose R.H., Thompson F.M., Baxter A.G., Pellicci D.G., and Cummins A.G. Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 52 (2007) 1415-1422
37. Snyder-Cappione J.E., Nixon D.F., Loo C.P., et al. Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J. Infect. Dis. 195 (2007) 1361-1364
38. Okumura A., Ishikawa T., Maeno T., et al. Changes in natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma. Hepatol. Res. 32 (2005) 213-217
39. Wilson S.B., Kent S.C., Patton K.T., et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391 (1998) 177-181
40. Barcelos W., Martins-Filho O.A., Guimaraes T.M., et al. Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment. Microbiol. Immunol. 50 (2006) 597-605
41. Veenstra H., Baumann R., Carroll N.M., et al. Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders. Clin. Exp. Immunol. 145 (2006) 252-260
42. Jing Y., Gravenstein S., Rao C.N., et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp. Gerontol. (2007)
43. Gadola S.D., Dulphy N., Salio M., and Cerundolo V. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. J. Immunol. 168 (2002) 5514-5520
44. - T cells. J. Exp. Med. 186 (1997) 109-120
45. Thomas S.Y., Hou R., Boyson J.E., et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171 (2003) 2571-2580
46. Kim C.H., Butcher E.C., and Johnston B. Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23 (2002) 516-519
47. Kim C.H., Johnston B., and Butcher E.C. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100 (2002) 11-16
48. Mempel M., Flageul B., Suarez F., et al. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire. Am. J. Pathol. 157 (2000) 509-523
49. + NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 168 (2002) 3140-3144
50. Ho L.P., Urban B.C., Jones L., Ogg G.S., and McMichael A.J. CD4(-)CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion. J. Immunol. 172 (2004) 7350-7358
51. Peralbo E., Alonso C., and Solana R. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp. Gerontol. 42 (2007) 703-708
52. Montoya C.J., Pollard D., Martinson J., et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122 (2007) 1-14